The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
D006333:Heart Failure / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology; D006341:Heart Rupture / Q000188:drug therapy / Q000209:etiology; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000209:etiology; D009203:Myocardial Infarction / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005996:Nitroglycerin / Q000627:therapeutic use; D009599:Nitroprusside / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D009599:Nitroprusside; D006830:Hydralazine; D005996:Nitroglycerin; D011224:Prazosin